• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CAT
Click for more information
0.00% $2.44

CATAPULT GROUP INTERNATIONAL LTD - Corporate Spotlight

Market Cap $657.7M  ! watchlist Created with Sketch. Add to my watchlist
Technology Software - Application

Catapult Group International Ltd is an Australia-based company engaged in sports... Catapult Group International Ltd is an Australia-based company engaged in sports technology solutions for professional teams. The Company’s products are designed to optimize performance, avoid injury, and improve return to play. The Company operates through three segments: Performance & Health, Tactics & Coaching and Media & Other. The Performance & Health segment is engaged in the design, development and supply of wearable technology and athlete monitoring software solutions to sports teams, athletes, and the prosumer market. The Tactics & Coaching segment is engaged in the design, development and supply of video analysis, editing, and publishing software solutions to sports teams. The Media & Other segment provides media licensing, athlete management and professional services to customers. Its wearable and video solutions are provided to elite clients on both a subscription and upfront capital sales basis. The Company works with more than 3,800 elite teams in over 40 sports.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
$2.44 		Change
0.000(0.00%) 		Mkt cap ! $657.7M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 1634 $2.63
 

Sellers (Offers)

Price($) Vol. No.
$2.44 250 1
View Market Depth
Last trade - 09.55am 02/10/2024 (20 minute delay) ?
Last
$2.49 		  Change
0.000 ( 2.04 %)
Open High Low Volume
$2.37 $2.49 $2.37 811
Last updated 10.15am 02/10/2024 ?
CAT (ASX) Chart

Top Stories

Firebird achieves preliminary approvals for its Jinshi plant design

Firebird Metals Ltd has reached a significant stage in development of its battery-grade manganese sulphate plant in China
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Canada orders national security review over CGN's 11.26% opposition to Paladin-Fission deal Paladin has disclosed its attempted takeover of Fission Uranium Corp was blocked by a Chinese shareholder late last month.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.